SynergAsia Health is a Singapore-based Contract Research Organisation with strong network in Asia to help sponsor proactively plan and execute all kind of trials. We have vast experience in working with medical community (physicians and hospital research unit) across Singapore, Taiwan, Korea, Hong Kong and Thailand.
Read More
SynergAsia Health has completed and are currently conducting several vascular clinical trials relating to novel interventional devices treating Peripheral Arterial Diseases (SFA, BTK), AVF and AVG. Such trials ranges from First-in-man to Double Blind Randomised Control trials.
Read MoreOur Mission is to bring novel technologies to patients, thereby improving the health of patients in a timely and cost-efficient manner.
SynergAsia Health is the choice for Medical
Devices Research especially in the Cardiovascular and Vascular Space.
SynergAsia Health offers a variety of services to clients to support all aspects of a clinical trial. We work very closely with our clients to...
SynergAsia Health is a trusted contract research partner with substantial expertise in complex interventional medical device...
You will be making a good choice in partnering with SynergAsia Health as your CRO. Our name means cooperation, and you can...
At SynergAsia Health, we put our focus on improving patients’ lives through clinical trials. Patient safety and data integrity are our main priorities, which will be fulfilled by regular monitoring of study data. Regular reporting to our clients will be done to maintain a close relationship during the trial.
We have supported several single centre trials which include the world’s first-in-man pilot study to investigate the safety and efficacy of the drug-eluting balloon (DEB). Apart from that, we also extend our expertise to run trials that involve drug-eluting stents (DES), arteriovenous graft (AVG) and arteriovenous fistula (AVF).
With our connections, we provide support to our clients not just locally, but also in a global setting. Our services will assist clients to run several kinds of multi-centre trials, regardless open-label, blinded, or randomised double-blind. Our team will provide all sites with as much support and assistance as possible to ensure all trials are running according each country’s regulation needs and requirements.
Our clients have achieved promising findings and we are committed to continue providing our support.
Our aim is to help clients deliver therapies which can transform healthcare to patients world-wide.
SynergAsia Health is the clinical research organization which clients believe in when they need to move their clinical evidence from...
Our team approach to instituting clinical and regulatory strategies is the foundation of achieving timely, and optimal tactical plans...
Our portfolio covers every niche of clinical research including trial design, protocol writing, trial management, and execution. Our expertise starts...
From product inception to market adoption, we assist our clients to maintain compliance as we steer the complex regulatory path to timely...
Data accuracy and reliability are the main priorities of our team. We excel in the collection of reliable, accurate and statistically sound data from...
We consider patient safety, data integrity, and protection of clients’ interests to be our topmost concern. We take full responsibility for the...
We leverage proprietary systems and processes for image transfer and real-time client access to data. The Imaging Core Laboratory works...
Our team knows that the foundation of a successful clinical program starts with a solid clinical and regulatory strategy. Whether you are preparing...
Sep 14Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the FUTURE SFA (Randomized...
Aug 12Concept Medical Inc. announced that it has been granted Breakthrough Device Designation (BDD) from the FDA for its MagicTouch percutaneous transluminal angioplasty (PTA) sirolimus-coated balloon...
We are currently open for discussion for any potential collaboration – If you would like to discuss further, do fill up the form here and we will get back to you shortly!
9am to 5pm
